New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Streptococcus bovis and CRC

Some research has suggested that only certain subspecies of S. bovis may be implicated in colorectal cancer.

Underestimating Prostate Cancer Tumors

A study reports that testing severely underestimated the aggressiveness of tumors in patients with prostate cancer.

High-Fat Diet and Breast Cancer Risk

Eating foods high in saturated fat may increase breast cancer risk, says new research.

Hypertension and Kidney Cancer Risk

A new study found that the risk of kidney cancer climbs as systolic blood pressure increases.

Menstrual Cycles, Ovarian Cancer

Irregular menstrual cycles may be an early marker of ovarian cancer risk.

Women 70+: No Routine Mammograms

Mammogram breast cancer screenings for women aged ≥70 may cause more harm than good.

FDA-Approved Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.


Statins May Reduce Risk of Progression of Renal Cancer

Statins May Reduce Risk of Progression of Renal Cancer

Results from the first study to directly examine the association between statin use at surgery and progression to metastasis or renal cell carcinoma death have been published.

Methylation-Specific Assay Can Detect Advanced Breast Cancer

Methylation-Specific Assay Can Detect Advanced Breast Cancer

A methylation-specific 10-gene panel can detect advanced breast cancer and reflects chemotherapy response.

Short-Term Anxiety Up With False-Positive Mammogram

Short-Term Anxiety Up With False-Positive Mammogram

False-positive mammogram results are tied to increased short-term, but not long-term, anxiety.

Fast Track Designation for Custirsen for mCRPC

The FDA granted Fast Track designation to custirsen when given in combination with cabazitaxel/prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) after prior treatment with a docetaxel-containing regimen.

Alvocidib Designated Orphan Drug in AML

The FDA has granted Orphan Drug designation to alvocidib (Tolero Pharmaceuticals) for the treatment of patients with acute myeloid leukemia (AML).


Make prescribing decisions with our comparative charts and treatment algorithms.


Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

Understanding Current and Emerging Therapies for Head and Neck CancersExternal web site

This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...

CE 0.50 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

A 63-Year-Old Female With Gastric AdenocarcinomaExternal web site

A 63-year-old Hispanic female, who presented with a syncopal episode while walking down the street, ...

CME 0.75 Credits
More myCME courses »

Sign Up for Free e-newsletters